161 related articles for article (PubMed ID: 26763362)
1. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
Shimoda K; Shide K; Kameda T; Hidaka T; Kubuki Y; Kamiunten A; Sekine M; Akizuki K; Shimoda H; Yamaji T; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A
J Clin Exp Hematop; 2015; 55(3):145-9. PubMed ID: 26763362
[TBL] [Abstract][Full Text] [Related]
2. TET2 mutation in diffuse large B-cell lymphoma.
Kubuki Y; Yamaji T; Hidaka T; Kameda T; Shide K; Sekine M; Kamiunten A; Akizuki K; Shimoda H; Tahira Y; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A; Shimoda K
J Clin Exp Hematop; 2017; 56(3):145-149. PubMed ID: 28331128
[TBL] [Abstract][Full Text] [Related]
3. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
4. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
6. Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.
Muto H; Sakata-Yanagimoto M; Nagae G; Shiozawa Y; Miyake Y; Yoshida K; Enami T; Kamada Y; Kato T; Uchida K; Nanmoku T; Obara N; Suzukawa K; Sanada M; Nakamura N; Aburatani H; Ogawa S; Chiba S
Blood Cancer J; 2014 Dec; 4(12):e264. PubMed ID: 25501021
[TBL] [Abstract][Full Text] [Related]
7. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
[TBL] [Abstract][Full Text] [Related]
8. Multistep tumorigenesis in peripheral T cell lymphoma.
Sakata-Yanagimoto M
Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Asmar F; Punj V; Christensen J; Pedersen MT; Pedersen A; Nielsen AB; Hother C; Ralfkiaer U; Brown P; Ralfkiaer E; Helin K; Grønbæk K
Haematologica; 2013 Dec; 98(12):1912-20. PubMed ID: 23831920
[TBL] [Abstract][Full Text] [Related]
10. Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.
Chan SM; Majeti R
Int J Hematol; 2013 Dec; 98(6):648-57. PubMed ID: 23949914
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
12. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract][Full Text] [Related]
13. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Kosmider O; Gelsi-Boyer V; Ciudad M; Racoeur C; Jooste V; Vey N; Quesnel B; Fenaux P; Bastie JN; Beyne-Rauzy O; Stamatoulas A; Dreyfus F; Ifrah N; de Botton S; Vainchenker W; Bernard OA; Birnbaum D; Fontenay M; Solary E;
Haematologica; 2009 Dec; 94(12):1676-81. PubMed ID: 19797729
[TBL] [Abstract][Full Text] [Related]
14. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
15. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of TET2 in hematologic malignancies.
Chiba S
Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
[TBL] [Abstract][Full Text] [Related]
17. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
18. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Quivoron C; Couronné L; Della Valle V; Lopez CK; Plo I; Wagner-Ballon O; Do Cruzeiro M; Delhommeau F; Arnulf B; Stern MH; Godley L; Opolon P; Tilly H; Solary E; Duffourd Y; Dessen P; Merle-Beral H; Nguyen-Khac F; Fontenay M; Vainchenker W; Bastard C; Mercher T; Bernard OA
Cancer Cell; 2011 Jul; 20(1):25-38. PubMed ID: 21723201
[TBL] [Abstract][Full Text] [Related]
19. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
20. [Significance of TET2 mutations in myeloid and lymphoid neoplasms].
Chiba S
Rinsho Ketsueki; 2016 Jun; 57(6):715-22. PubMed ID: 27384850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
